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1. Introduction 
Pancreatic acinar cells have distinct binding sites 
for secretin and pancreozymin [l-3] . Each gastro- 
intestinal hormone stimulates a membrane adenylate 
cyclase system through the activation of a common 
catalytical unit [4,5] . As in other eukaryotic systems 
[6-lo] guanine nucleotides are positive activators of 
the hormone stimulated enzyme activity [ 1 l] . In 
numerous systems [ 12-171, when p(NH)ppG (a stable 
analog of GTP) and a hormone are used in combina- 
tion, there results a permanent activation of adenylate 
cyclase, i.e., durable high activity resisting extensive 
washing or exposure to a hormone antagonist. In 
turkey erythrocyte plasma membranes permanently 
activated by 1 -epinephrine and p(NH)ppG, this state 
was shown to be reversible provided epinephrine and 
GTP were added simultaneously [15-l 71. The 
hormone produced two added effects: (a) the release 
of bound p(NH)ppG [ 161, and (b) the activation of 
a membrane specific GTPase [ 18,191. 
We investigated the mechanism for persistent 
activation of pancreatic adenylate cyclase and its 
possible reversibility by deactivation, by taking 
advantage of the coexistence of two independent 
hormone receptors capable of interacting with a uni- 
que effector subunit. The data are compatible with a 
model postulating that hormone receptors and the 
adenylate cyclase effector are not permanently coupled 
in the active state and that two guanyl nucleotide 
regulatory sites are involved, one promoting enzymatic 
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activity of the catalytic subunit and another associated 
with a hormone receptor and acting to transduce the 
hormonal signal. 
2. Materials and methods 
(a) Natural porcine secretin and the synthetic 
C-terminal octapeptide of cholecystokinin-pancreo- 
zymin (OC-PZ) were generous gifts from, respectively, 
Dr V. Mutt (Karolinska Institutet, Stockholm, 
Sweden) and Dr M. Ondetti (Squibb Institute for 
Medical Research, Princeton, N.J., USA). 
[(w-“P]ATP and cyclic[3H]AMP were purchased 
from The Radiochemical Center (Amersham, Great 
Britain). Guanosine (P-7 imido)triphosphate 
(p(NH)ppG) and GTP were obtained from Boehringer 
(Mannheim, Germany). ATP, phospho(enol)pyruvate, 
pyruvate kinase and cyclic AMP were obtained from 
Sigma Chemical Co. (St. Louis, MO., USA). All other 
reagents were commercial preparations of analytical 
grade. 
(b) Rat pancreatic plasma membranes were pre- 
pared as previously described [5] and stored in liquid 
nitrogen until use. 
(c) Adenylate cyclase assay: Membranes (2-10 pg 
protein) were incubated for 10 min at 37’C in a final 
volume of 0.06 ml in a medium previously detailed 
[ 111. Cyclic AMP was extracted by sequential 
chromatographies [20]. The enzyme activity observed 
in the presence of 30 /.IM p(NH)ppG with 0.3 I.IM 
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OC-PZ and/or 0.3 PM secretin was that allowing 
maximal activity [ 111 . 
(d) Persistent activation of pancreatic adenylate 
cyclase: l-2 mg membrane protein were incubated 
at 30°C in the combined presence of 30 E.~M p(NH)ppG 
and of 0.3 PM OC-PZ or 0.3 PM secretin (i.e., saturat- 
ing concentrations, ref. [ 111) in a medium containing 
50 mM Tris-HCl buffer (pH 7.4), 5 mM MgClz, 5 mM 
dithioerythritol, and mixed hepatic phospholipids 
(0.2 mg/ml). The final volume was 2.4 ml. The 
incubation was stopped by adding 7 ml of ice-cold 
washing buffer A composed of 20 mM Hepes-Tris 
(pH 7.4) with 0.1 mM MgC12, 30 mM NaCl, and 
0.1 mM dithioerythritol. After immediate centrifuga- 
tion at 50 000 X g for 5 min at O”C, the pellet was 
rehomogenized in buffer A and centrifuged again; 
this procedure was repeated three times. Washed 
membranes were finally resuspended in buffer A, 
sonicated (3 X 0.5 s) and assayed for adenylate 
cyclase activity in the stand_ard medium with or with- 
out 30 PM p(NH)ppG, and with or without the 
simultaneous presence of 0.3 FM OC-PZ or 0.3 PM 
secretin. The catalytical activity attainable with 
p(NH)ppG and hormone together was considered as 
maximal and the persistent activity observed in these 
membranes was expressed as percent of this maximal 
activity. 
(e) Deactivation of adenylate cyclase in a persistent 
active state: Plasma membranes were preactivated as 
described at the beginning of the previous paragraph 
but their dispersion was obtained by homogenization 
in buffer A rather than by sonication. Dilution and 
incubation were conducted in buffer B, made of 
30 mM Tris-HCl (pH 7.4), 5 mM MgCl?, 0.5 mM 
EGTA, mixed phospholipids (0.2 mg/ml), 10 mM 
phospho(enol)pyruvate, pyruvate kinase (30 I.rg/ml), 
0.5 mM ATP (to protect GTP from degradation [ 1 l] ), 
and without or with 30 PM GTP, and/or the hormone 
tested at saturating concentration. At iiarious time 
intervals, the membranes were washed three times at 
0°C by the above mentioned procedure. The washed 
pellet was sonicated in buffer A to a final membrane 
protein concentration of 0.1-0.2 mg per ml. The 
residual persistent adenylate cyclase activity was 
determined as described in paragraph (d). 
(f) Protein determination was performed by the 
method of Lowry et al. [21]. 
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3. Results 
Incubation of rat pancreatic plasma membranes 
with p(NH)ppG alone or in the presence of the 
nucleotide and OC-PZ or secretin led to a persistent 
activation of adenylate cyclase, i.e., maximal activity 
resisting extensive washing by centrifugation- 
resuspension at 0°C. The rate of persistent activation 
was hormone-responsive. In the combined presence 
of saturating concentrations of p(NH)ppG and 
peptide hormone, a 5 min incubation at 30°C sufficed 
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Fig.1. Time study of the persistent activation of pancreatic 
adenylate cyclase. Pancreatic plasma membranes were 
incubated at 30°C in 2.4 ml of 50 mM Tris-HCl buffer 
(pH 7.4) containing 5 mM MgCl, and 2 mM dithioerythritol 
and with 30 PM p(NH)ppG alone (A-A-A) or in the presence 
of 0.3 rM OCPZ (o-o-o) or 0.3 PM secretin (e-4) (saturating 
concentrations, ref. [ 111). At indicated times, 0.3 ml aliquots 
were removed, diluted with 6 ml of cold washing buffer A 
and stored at 0°C until the end of the time study. The mem- 
branes were then washed as indicated in the experimental 
section, and finally sonicated (3 X 0.5 s) in 0.15 ml of wash- 
ing buffer A. Aliquots of 0.02 ml were assayed in triplicate 
for adenylate cyclase activity under two conditions: in the 
standard assay medium or in the combined presence of 
saturating concentrations of p(NH)ppG (30 PM), OC-PZ 
(0.3 PM), and secretin (0.3 NM). The value attained with the 
activators (0.66 f 0.04 nmoles of cyclic AMP . min-’ . mg 
prot-‘) was considered as the maximal evel of adenylate 
cyclase activity. Activities observed in the simple standard 
assay medium were considered as representing the persistent 
activation attained during the time study and were expressed 
as a fraction of maximal activation. Each time study was a 
separate xperiment. 
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to achieve full persistent activation whereas the 
activation was much slower with the nucleotide 
alone, a 30 min incubation allowing only half-maximal 
persistent activity (fig.1). 
The persistently active state was reversible provided 
OC-PZ and GTP (or ATP) were added together (fig.2). 
Kinetic data show that in the presence of OC-PZ and 
GTP, 50% of the permanent activity was lost during 
0.3pM OC-PZ:O 0 + + + + 
30pM GTP :o + 0 0 + + 
0.5 mM ATP :o + 0 + 0 + 
Fig.2. Conditions required for the reversible deactivation of 
persistently activated adenylate cyclase. Pancreatic plasma 
membranes were fully activated by a 10 min preexposure to 
30 PM p(NH)ppG and 0.3 NM OC-PZ as described under 
section 2. After 3 washings, they were resuspended and 
then incubated for 10 min at 37°C in a fmal volume of 
0.3 ml of ATP-free buffer B in the presence (+) or 
absence (0) of 0.5 mM ATP, 30 PM GTP and 0.3 PM OC-PZ. 
The membranes were then washed three times and sonicated 
in 0.2 ml of buffer A. Adenylate cyclase activities were 
assayed in triplicate in 0.02 ml aliquots under control con- 
ditions or in the combined presence of 30 PM p(NH)ppG, 
0.3 MM OC-PZ, and 0.3 PM secretin. The value attained with 
activators represented maximal adenylate cyclase stimulation 
and the activities obtained in the control medium were 
expressed as a fraction of this maximal stimulation. The two 
separate xperiments were performed with membranes having 
a maximal adenylate cyclase activity of, respectively, 0.64 
and 1.05 nmol of cyclic AMP * min-’ * mg prot-‘. 
the first 15 min and then followed a slower rate of 
deactivation (fig.3). Each peptide and nucleotide was 
ineffective if used alone (fig.2). The deactivation 
obtained could be reversed by repetition of the activa- 
tion procedure. 
The’persistent activation caused by secretin and 
p(NH)ppG could be reversed by OC-PZ and GTP. 
Similarly the persistent activation caused by OC-PZ 
and p(NH)ppG could be reversed by secretin in the 
presence of GTP (table 1). Such deactivation by the 
reciprocal hormone was somewhat less efficient than 
that provoked by treatment with the same hormone 
which had been used in the activation procedure but 
this might simply reflect the protection of the corre- 
sponding receptor afforded by the hormone during the 
preactivation step. 
0.3 /JM OC-PZ 
+ 30 pM GTP 
8 I I I 1 
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Deactivation time ( min ) 
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Fig.3. Kinetics of reversal of the persistently active state of 
pancreatic adenylate cyclase. Membranes were persistently 
activated by 30 MM p(NH)ppG and 0.3 PM OCPZ as 
described under section 2. After 10 min of pre-incubation, 
the membranes were washed three times, homogenized and 
incubated in 1.2 ml of buffer B enriched with 30 PM GTP 
and in the presence (e-e-o-) or absence (o-o-o) of 0.3 PM 
OC-PZ. The extent of deactivation was monitored by 
removing 0.2 ml aliquots at the indicated times, dilution by 
7 ml of cold buffer A and storage at 0°C. At the end of the 
time study, all membrane aliquots were centrifuged and 
washed three times (see under section 2). Persistent adenylate 
cyclase stimulation was assayed and expressed as described in 
fig.2. Means f SEM of four separate xperiments. The maxi- 
mal adenylate cyclase activity was 0.68 f 0.10 nmol cyclic 
AMP . min-’ * mg-‘. 
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Table 1 
Cross-deactivation of persistently activated pancreatic adenylate cyclase by 
OC-PZ and by secretin 
Number of experiments 4 5 3 
Step I: Activation with 
30 /JM p(NH)ppG 
0.3 PM hormone 
+ + + 
oc-PZ secretin 0 
Step II: % of maximal activity after 
a 10 min deactivation with 
(a) 30 PM GTP 
(b) 30 /.IM GTP + 0.3 /.tM OC-PZ 
(c) 30 PM GTP + 0.3 PM secretin 
(d) 30 NM GTP + 0.3 /.IM OC-PZ 
+ 0.3 crM secretin 
93* 5 7Ok 4 442 7 
(100) (lob) (100) 
48 + 7 57 k 3 22 f 2 
(52) (81) (51) 
59+ 5 44 k 4 32 f 3 
(63) (63) (72) 
35 f 2 44 f 5 24 f 3 
(38) (63) (54) 
Step I: Plasma membranes were persistently activated by either incubation for 
10 min at 30°C with 30 PM p(NH)ppG used in combination with 0.3 NM OC-PZ 
or 0.3 PM secretin, or for 30 min at 30°C with 30 NM p(NH)ppG alone, The mem- 
branes were then washed 3 times to remove free and loosely bound activators. 
Their maximal activity was 0.76 + 0.08 nmoles cyclic AMP . min-’ . mg prot-‘. 
Step II: These preactivated membranes were incubated in 0.3 ml of buffer B 
enriched with 30 pM GTP and in presence or absence of added hormone(s). After 
10 mm at 37”C, the membranes were washed 3 times and sonicated in 0.2 ml of 
buffer A. Aliquots of 20 ~1 were assayed for adenylate cyclase activity in the 
standard medium or in the presence of 30 PM p(NH)ppG with 0.3 PM OCPZ and 
0.3 PM secretin. Persistent activation was expressed in percent of maximal adenylate 
cyclase activity as in fig.2. The values in parentheses give the residual persistent 
activation expressed in percent of the control deactivation procedure, conducted 
with 30 PM GTP only. Allvaluesare the mean f SEM of 3-5 separate xperiments 
4. Discussion 
According to a well documented model [22,23] 
and to previous observations [ 1 l] , the activation of 
rat pancreatic adenylate cyclase by GTP and a hor- 
mone begins with the rapid binding of GTP followed 
by a molecular transition which leads to its activation. 
The rate constants of this transition can be increased 
by secretin and OC-PZ. This can be formulated as 
follows: 
kr k2 ka 
E + GTP -E.GTP &E?GTP 4E + GDP + Pi 
1_; k_2 
where E represents the basal form of adenylate cyclase 
and E* the active form of the enzyme. E is regenerated 
354 
at a rate determined by k3 corresponding to the 
irreversible hydrolysis of GTP by a GTPase activity 
associated with E [18,19]. 
When a non-hydrolyzable analog of GTP G’ and 
not GTP is used, the value of k3 is nil and the 
reversibility of the activation can only be achieved 
by returning to states E.G’ and E with the corre- 
sponding rate constants k_2 and k_, , the determining 
step being the conversion of ElrG’ into E.G’ [ 111. 
In state E?G’ the GTP analog is bound and its con- 
formation can modulate the activity of E* : this is why 
p(NH)ppG, p(CH?)ppG and GTPyS allow distinct app. 
V values for E* [24] : 
E+G’& E.G’ 
kz, 
x- 
EiCG’-Jt) 
k 
-1 -2 
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The two major conclusions warranted by the pres- 
ent data on rat pancreatic plasma membranes justify 
an extension of the preceding model: 
(1) The active state E* obtained in the presence 
of p(NH)ppG and persisting after extensive membrane 
washing (i.e., after removal of free hormone and 
nucleotide) could be reversed only when a hormone 
and GTP were added simultaneously. (We confirmed 
(tig.2) that ATP at a 0.5 mM concentration could 
partially mimic the effects of GTP [ 171.) Since E* 
required the durable occupation of a regulatory 
guanyl binding site (see above), the added nucleotide 
needed for deactivation must bind to another site 
probably coupled with the hormone receptor. This is 
further indirect evidence of the existence of two guanyl 
binding sites in addition to the evidence recently 
documented in liver plasma membranes [25] . Another 
argument favoring the existence of a specific. guanyl 
nucleotide site controlling hormone binding in rat 
pancreatic plasma membranes is the marked increase 
in the rate of dissociation of [ 3H] caerulein (an analog 
of OC-PZ) and of [“‘I]VIP (a parent hormone of 
secretin) in the presence of guanyl nucleotides 
([3,26] and unpublished data). Thus the first guanyl 
regulatory site appears essential in the permanent 
activation of E by p(NH)ppG while the second guanyl 
regulatory site, when occupied, might stimulate the 
transduction of the hormone-generated signal and also 
enhance the rate of dissociation of the membrane 
bound hormone. 
(2) In the presence of GTP, the reversibility of the 
persistently active state of pancreatic adenylate cyclase 
was achieved by secretin as well as by OC-PZ irrespec- 
tive of the hormone used to promote activation. From 
previous studies it is apparent that the hormone 
receptors and E are not permanently bound in the 
absence of a hormone [27-301. In pancreatic mem- 
branes full and rapid activation required the simul- 
taneous presence of a hormone and of a guanyl 
nucleotide, suggesting the involvement of an inter- 
mediate complex H.R.G.E.G. These results might be 
explained in either of two ways: (1) a tight constant 
association of OC-PZ receptors with secretin receptors; 
this hypothetical clustering of distinct hormone 
receptors is unlikely since both peptides cannot com- 
pete at the level of their binding sites [3] therefore 
suggesting the spatial independence of their receptors; 
(2) the uncoupling of the first hormone receptor so 
that the enzymatic effector can now diffuse in the 
plane of the cell membrane and interact with another 
hormone bound receptor during the deactivation 
process; this model requires the existence of the free 
E* species. It ressembles the collision coupling mech- 
anism recently developed by Tolkovsky and Levitzki 
[32] for turkey erythrocyte membranes on the basis 
of another experimental approach. 
To conclude, the following tentative model fits the 
present results and differs from those in which the 
hormone bound receptor and the effector remain 
associated in the active state [27,28] and those in 
which the only guanyl regulatory site is a GTPase 
bound to the catalytic subunit: 
(a) The process leading to permanent activation in 
the presence of OC-PZ (H’) and p(NH)ppG includes 
the formation of a transient complex H.‘R’E. 
requiring the binding of p(NH)ppG to two regulatory 
sites which are coupled, respectively, with R’ and E. 
A molecular transition (k,) leads to a complex and 
highly active state in equilibrium with the free active 
effector species E* holding one p(NI-I)ppG. The 
washing of membranes shifts the equilibrium in favor 
of the free active effector species: 
R’ +E %HH!R’[G’] &[G’]+ 
-2 
-HI;- G’ 
H!R’ [G’] .E* [G’] . -RI +E*[G’] 
where G’ represents p(NI-I)ppG 
(b) The deactivation of persistent activation 
observed when secretin (Hz) and GTP are offered 
simultaneously to washed membranes begins with the 
coupling of E* with H?R’. Next p(NH)ppG is 
exchanged for GTP and deactivation is achieved by 
the washing of the membranes and the hydrolysis of 
GTP (thanks to the GTPase activity present in E): 
R2 + E* [G’] 
H?R2 [G] B[G’] .- G’; + GaH?R2 [G] .,!T[G] 
-Hz; - GDP; - P. 
+ R2 +E; 
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where G’ and G represent p(NI-I)ppG and GTP, 
respectively. 
(c) The same final deactivation isattained when 
OC-PZ (H’) and R1 are used again instead of secretin 
(Hz) and R'. 
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